USA: Children the Critical Casualties of Commercial Cannabis

Over 100 Child Abuse Deaths Found Related to Cannabis, with Rise of Commercial Industry

Shortly after Colorado commercialized marijuana in 2014, stories of three tragic deaths of toddlers related to their parents’ use of marijuana emerged. The month Washington legalized possession of marijuana, a two-year-old drank from his mother’s bong and died. After investigating, state officials determined that the toddler had ingested lethal amounts of both THC and meth, enough to kill an adult.

“As articles in popular magazines such as Cosmopolitan and Oprah Winfrey’s ‘O’ portray cannabis as the ‘it’ drug, parents are being led to believe that a serving of marijuana is no more dangerous than a glass of beer or wine,” explains Dr. Ken Finn, a medical advisor to “However, three sets of twins died in fires when parents abandoned these toddlers for reasons related to their marijuana use.”

The promotion of marijuana as a way to relax is inappropriate for parents or caregivers of small children, and the promotion of marijuana for pregnant women with morning sickness is a dangerous trend.

Marijuana use impairs executive functioning — which led to poor judgement and forgetfulness in many of these deaths. Greater acceptance means more use, and more use means more addiction.

Eleven deaths occurred in Colorado, while 10 took place in California. In both states, at least one child died where butane hash oil (BHO) labs operated, and numerous children were injured in BHO fires. The two most recent deaths in Colorado occurred last summer when a mother followed a cult leader to a marijuana farm. No one knows how long the two girls had been dead when they were discovered locked in a car covered in tarp last September. They were starved to death. An unusual death in California occurred when a babysitter went to her cousin’s car to smoke pot, leaving a 16-month-old boy inside. The toddler eventually came outside and the visiting car ran over him…

For complete article


Posted in Uncategorized | Leave a comment

USA: Vermont Weed Warriors Defeated Again – Sanity Rules, at least this time!


BREAKING: Marijuana Legalization Defeated Again in Vermont
National Marijuana Policy Group Applauds Defeat of Marijuana Commercialization in Vermont
For Immediate Release:
Monday, April 30, 2018
Contact: Colton Grace
[Montpelier, VT] – On Friday, the Vermont House of Representatives overwhelmingly voted to kill a bill that would have fully legalized the commercialization of marijuana. This was another crushing defeat for the active pro-pot movement in Vermont, which has been trying to legalize pot sales for several years.
“This sudden action by some in the legislature, dubbed a ‘Hail Mary’ by local media, tried to resurrect a bill that had been lying dormant all session,” said Ginny Burley, spokesperson for Smart Approaches to Marijuana Vermont (SAM-VT), a project of Smart Approaches to Marijuana Action (SAM Action). “At SAM-VT we believe that any such bill needs a thorough discussion and should not be rushed through. We are already engaged in educating the community on the implications of Act 86, the legalization of home grow, which passed recently. SAM-VT is pleased that cooler heads prevailed,” continued Burley.
Proponents of the bill argued that Vermont was wasting an opportunity to collect large tax revenues by legalizing personal use of marijuana without setting up a legal retail system. These arguments fall flat by not recognizing the  societal costs of marijuana legalization such as increased drugged driving fatalities and other vehicle related property damages, short term health costs, and increased workplace absenteeism and accidents.
“This is a huge victory for public health and safety,” said Dr. Kevin Sabet, Founder and president of SAM and SAM Action. “The pot lobby pushed for full legalization by dangling the prospects of large tax revenues over the heads of Vermonters, but Vermont lawmakers saw right through it. Thanks to the terrific work by SAM VT, this bill is dead and marijuana sales will not be legalized,” continued Sabet.
Marijuana advocates argue that polls show massive support for legalization fail to point out that, when given the option of decriminalization, support for full legalization falls drastically.
Additionally, although advocates have repeatedly claimed that marijuana legalization would be a victory for social justice, data show arrest rates among minority youth have increased in states like Colorado.
The commercialization of marijuana would serve only to create a large, powerful marijuana industry that would become the next Big Tobacco. Comprehensive studies out of  Connecticut and  Illinois show that the costs of marijuana legalization far outweighs projected tax revenues even under conservative estimates.

About SAM Action

SAM  Action is a non-profit, 501(c)(4) social welfare organization dedicated to promoting healthy marijuana policies that do not involve legalizing drugs. Learn more about  SAM  Action and its work at visit


Posted in Uncategorized | Leave a comment

Global: Actual Marijuana Based Medicine, not Weed Witch-doctory!

Why marijuana fans should not see approval for epilepsy drug as a win for weed

April 20, 2018

A Food and Drug Administration panel recommended approval of a drug made of cannabidiol on April 19 to treat two types of epilepsy. The FDA is expected to decide in June whether to accept the panel’s 13-0 recommendation to approve Epidiolex, which would would become the first drug made of cannabidiol, a compound in the cannabis plant, to gain approval from the FDA.

While the panel’s unanimous decision is not binding, the action will no doubt heighten public debate about the use of cannabidiol, medical marijuana, medical cannabis and hemp oil. Should cannabidiol, or CBD, or marijuana be legalized for medical purposes? What is the evidence that these products are beneficial? Are these products safe to use?

Those who support the use of marijuana for recreational or medicinal purposes might have found the timing of the panel’s ruling interesting. National Weed Day is April 20.

But weed is not cannabidiol, even though both come from cannabis.

As a professor of pharmacy with a special interest in epilepsy, I find it important that CBD may be a new option for the treatment of epilepsy. This new use has led me to carefully study published literature on CBD and discuss it as an option with patients who have epilepsy. Additionally, I have been involved with the American Epilepsy Society’s ongoing review of CBD as a possible treatment for epilepsy. From this perspective, I believe that CBD may offer benefits for patients with some types of epilepsy and possibly other disorders.

No high, but healing?

The cannabis plant produces hundreds of different compounds, many of which have differing effects in the body. Tetrahydrocannabinol, or THC, is the substance that is most known for its psychoactive effects, or the “high” associated with marijuana.

However, there are many other substances from the cannabis plant that also produce effects in the body. Many of these differ from THC in that they are not psychoactive – and they do not produce a “high.” Cannabidiol, or CBD, is one of those substances.

Compared to THC, CBD works at different receptors in the brain and other parts of the body. In this way, CBD is very different from THC and may offer new mechanisms of treatment. For this reason, CBD has received a great amount of attention as a possible treatment for many different disorders.

However, there are two well-designed, large studies that indicate CBD is effective in two different epilepsy syndromes. In these studies, about 40 percent of patients taking CBD had a significant reduction in specific types of seizures.

For more

Also see  THE ONLY REAL CANNABIS BASED MEDICINE – Pharmaceutically Tested, not ‘home spun quackery’!

But caution still very much needed as CBD and CBN continue to have ‘red flags’ around their potential teratogenic and mutagenic properties!


Posted in Uncategorized | Leave a comment

USA: Suicide – A Silent Contributor to Opioid-Overdose Deaths

As the toll of opioid-overdose deaths in the United States rises, we face an urgent need for prevention. But preventing such deaths will require a better understanding of the diverse trajectories by which overdoses occur, including the distinction between intentional (suicide) and unintentional (accidental) deaths, be they in patients with chronic pain who overdose on their opioid analgesics or in those with a primary opioid use disorder (OUD). Interventions to prevent overdose deaths in suicidal people will differ from interventions targeted at accidental overdoses. Yet most strategies for reducing opioid-overdose deaths do not include screening for suicide risk, nor do they address the need to tailor interventions for suicidal persons. Moreover, the inaccuracy of available data on the proportion of suicides among opioid-overdose deaths — which are frequently classified as “undetermined” if there is no documented history of depression or a suicide note — hinders deployment of appropriate prevention services.

In 2016, the Centers for Disease Control and Prevention (CDC) reported 42,000 opioid-overdose fatalities, including an unknown number of suicides. Notably, two populations that are more likely than others to receive opioid prescriptions — patients with chronic pain and those with mood disorders — are also at greater risk for suicide. Patients with a substance use disorder are at increased risk for suicide as well, and although opioid overdoses are uncommon among suicide attempts in such patients, suicides by poisoning are far from rare. Difficulties in ascertaining the manner of death probably result in the underreporting of opioid-overdose deaths as suicides.1

The distinction between unintentional and volitional deaths may be blurred among people with OUD, whose motivation to live might be eroded by addiction. Such erosion can have a range of effects, from engagement in increasingly risky behaviors despite a lack of conscious suicidal intent to frank suicidal ideation and intent. This entire spectrum can lead to opioid-overdose deaths, but little attention has been given to its contribution to overdose mortality.

Of the estimated 44,965 suicides in the United States in 2016, about 50% were carried out by firearm and about 15% by drug overdose, according to the CDC. The proportion of suicides that were opioid overdoses rose from 2.2% to 4.3% between 1999 and 2014, with the highest increases occurring among people 45 to 64 years of age.2 On the other hand, 17% of drug-related deaths (all drugs, not only opioids) in 2010 were classified as suicides.3 Similarly, an analysis of opioid-overdose deaths in Utah in 2008 and 2009 showed that 21% of 2086 such deaths were attributed to suicide and 16% were classified as undetermined.4 Even people deemed to have died of an “unintentional overdose” frequently had suicide risk factors: depression, substance use disorders, and financial problems. Among those who died from an overdose of an illicit drug (including opioids), the age-adjusted rate of intentional overdose (suicide) increased by 61% in urban areas and 84% in nonurban areas between 1999 and 2015.3Nonetheless, the percentage of the estimated 42,000 opioid-overdose deaths in 2016 that were suicides is not well documented.

One challenge in determining the manner of death in opioid-overdose fatalities is that the medical examiner or coroner cannot know the decedent’s intent with certainty. Absent a suicide note, determinations are based on autopsy, information collected at the scene of death, and circumstantial evidence. Indeed, percentages of overdose deaths classified as undetermined vary greatly from state to state, ranging from 1% to 85% between 2008 and 2010, with an average of 8%.5 Sources of variability include individual factors (e.g., observer bias, fear of litigation), system factors (e.g., variability in definitions, death-scene investigations), and state-level factors (e.g., variation in classification of multidrug overdoses). The CDC recently called for actions such as standardization of definitions and practices and protection against litigation to reduce this variability.5 Although the percentage of deaths classified as undetermined dropped to 6.7% between 2011 and 2014, the absolute number of deaths from overdoses of undetermined intent has increased significantly as overdose fatalities have more than tripled between 1999 and 2016.

Similarly, 2014 data from the National Survey of Drug Use and Health showed that an OUD involving prescription opioids was associated with an increase of 40 to 60% in the risk of suicidal ideation, after controlling for overall health and psychiatric conditions. People using opioids regularly were at greatest risk: they were about 75% more likely to make suicide plans and twice as likely to attempt suicide as people who did not report any opioid use. Though suicidal ideation and attempts are not the same as suicide deaths, they are predictors of eventual suicide.

Perhaps of most relevance, 2006–2011 data from the Nationwide Emergency Department Sample that include information on more than 250,000 emergency department visits by adults for opiate overdose show that only 54% of the overdoses were classified as “unintentional”: 26.5% were deemed intentional, and 20.0% were “undetermined.” The data also document a steady annual increase in opiate-overdose visits to emergency departments. Together, these data suggest that the true proportion of suicides among opioid-overdose deaths is somewhere between 20% and 30%, but it could be even higher.

Educational campaigns to increase public awareness of suicide risk could engage family and friends in interventions to prevent suicidal overdoses by seeking medical assistance. Campaigns to reduce the double stigma associated with suicide and drug addiction might make patients more willing to seek treatment.

In parallel, research to evaluate the mechanisms underlying the high rate of suicidal behavior in patients with chronic pain and in those with OUD could help guide development of prevention and therapeutic strategies. Research should also evaluate which are the most effective treatment interventions in people with OUD who are also at high risk for suicide, as well as interventions targeting risk factors that have only recently begun to be studied, such as low motivation to live. Finally, research aimed at the development and validation of screening tools to help characterize suicide risk along a continuum of awareness regarding suicidal intent would improve identification of persons who are at greater risk.

The significant increases in both opioid-overdose deaths and suicide rates in our country have contributed to reduced life expectancy for Americans. These two epidemics are intermingled, and solutions to address the opioid crisis require that we tailor interventions to preventing opioid-overdose deaths due to suicidal intent.

For complete article


Posted in Uncategorized | Leave a comment

USA: S.A.M Breaking News!



Medical Marijuana Users More Likely to Abuse Prescription Drugs

A groundbreaking new study from the Journal of Addiction Medicine finds that medical marijuana users are more likely to use prescription drugs both medically and non-medically. The study recommends that doctors of patients who use medical marijuana must use more caution in prescribing medicines as those patients are more likely to abuse them. Essentially, more medical marijuana means more prescription drug abuse.

Click  here to read more.

Colorado Schools Report 19% Increase in Marijuana Suspensions

New numbers out of Colorado shows a large increase in students being suspended for using marijuana. Administrators say that increased availability of marijuana in Colorado has led to the increase of marijuana-related suspensions statewide.  Click  here to read more.

About SAM: Smart Approaches to Marijuana (SAM) is a nonpartisan, non-profit alliance of physicians, policy makers, prevention workers, treatment and recovery professionals, scientists, and other concerned citizens opposed to marijuana legalization who want health and scientific evidence to guide marijuana policies. SAM has affiliates in more than 30 states. For more information about marijuana use and its effects, visit



Posted in Uncategorized | Leave a comment

UK: Cannabis is Killing our Kids – potential, purpose and even their lives!

Think it’s harmless? Now nine in ten teens at drug clinics are being treated for marijuana use

  • Cannabis is responsible for 91% of drug addiction cases involving teenagers
  • Skunk – high-potency herbal cannabis – causing more people to seek treatment
  • Backs up research that skunk is having detrimental impact on mental health

By Stephen Adams and Martin Beckford for The Mail on Sunday PUBLISHED: 22 April 2018

Cannabis is responsible for 91 per cent of cases where teenagers end up being treated for drug addiction, shocking new figures reveal.

Supporters of the drug claim it is harmless, but an official report now warns the ‘increased dominance of high-potency herbal cannabis’ – known as skunk – is causing more young people to seek treatment.

The revelation comes amid growing concerns that universities – and even some public schools – are awash with high-strength cannabis and other drugs.

The findings also back up academic research, revealed in The Mail on Sunday over the past three years, that skunk is having a serious detrimental impact on the mental health of the young. At least two studies have shown repeated use triples the risk of psychosis, with sufferers repeatedly experiencing delusional thoughts. Some victims end up taking their own lives.

The latest UK Focal Point on Drugs report, drawn up by bodies including Public Health England, the Scottish Government and the Home Office, found that:

Cannabis is responsible for 91 per cent of cases where teenagers end up being treated for drug addiction, shocking new figures reveal (file photo)

  • Over the past decade, the number of under-18s treated for cannabis abuse in England has jumped 40 per cent – from 9,043 in 2006 to 12,712 in 2017;
  • Treatment for all narcotics has increased by 20 per cent – up from 11,618 to 13,961;
  • The proportion of juvenile drug treatment for cannabis use is up from four in five cases (78 per cent) to nine in ten (91 per cent);
  • There has been a ‘sharp increase’ in cocaine use among 15-year-olds, up 56 per cent from 16,700 in 2014 to 26,200 in 2016.

Last night, Lord Nicholas Monson, whose 21-year-old son Rupert Green killed himself last year after becoming hooked on high-strength cannabis, said: ‘These figures show the extent of the damage that high-potency cannabis wreaks on the young.

‘The big danger for young people – particularly teens – is that their brains can be really messed up by this stuff because they are still developing biologically. If they develop drug-induced psychosis – as Rupert did – the illness can stick for life.’

Lord Monson said: ‘We really need Ministers to get a grip and launch a major publicity campaign about the dangers.’

For complete article:





Posted in Uncategorized | Leave a comment

GLOBAL: S.A.M. eNews Update

News Roundup
April 2018
It’s been a busy month!
Together, we are making a difference!

On “4/20,” SAM Highlights Harms of Marijuana With Former Congressman  Patrick Kennedy & Medical, Legal, and Government Experts at National Press Club New Study Finds Marijuana Legalization Will Cost Illinois $670 Million
SAM officials, including a former Congressman and the nation’s first African-American magistrate judge, joined members of the New Jersey Legislative Black Caucus, faith-based leaders, researchers from the National Institutes of Health, and other public health and safety experts at a press conference warning about the dangers of marijuana and the explosion of high potency THC.
“We’re sounding the alarm today – during the unofficial ‘marijuana holiday’ – about pot edibles, candies, waxes, and other items used to hook kids on THC,” said Former Congressman Patrick J. Kennedy, Honorary Chair of SAM. “This is the public health crisis we cannot afford to ignore…”
Healthy and Productive Illinois (HPIL) - a project of Smart Approaches to Marijuana Action (SAM Action) - released a comprehensive working paper on the projected costs of legalization in Illinois, finding that legalization would cost the state $670.5 million, far outweighing estimated tax revenue projections of approximately $566 million.
This report used data from states like Colorado that have legalized marijuana to debunk the myth that taxed marijuana sales will be a boon to the state’s well-reported fiscal crisis…

SAM’s 2018 Summit A Huge Success!

A big thank you to everyone who attended our 5th Annual SAM Summit in Atlanta, GA last week! In case you were unable to make it, hundreds of  advocates, victims of marijuana, substance abuse counselors, doctors, members of law enforcement, and other concerned citizens convened to listen to excellent speakers and discuss the dangers of marijuana legalization.

Headliners included top federal officials, former NIDA Head Toxicologist Dr. Marilyn Huestis, and more.

New Poll Offers False Dichotomy, Skews Illinois Voters’ View On Marijuana

SAM Action and Partners Force Stalemate on Pro-Pot Appropriations Riders
The Paul Simon Public Policy Institute recently released a  poll of Illinois voters that purported to show overwhelming support for the legalization of marijuana. The poll showed that 66% of voters in the state were supportive of the legalization of marijuana if it is taxed and regulated like alcohol.
But if you ask a poorly-phrased question, you get a poorly-understood response. In contrast, a recent Mason-Dixon poll shows only 23% of Illinois voters support legalization when given other options.
While the Rohrabacher-Leahy Amendment was ultimately included in the Fiscal Year 2018 Omnibus Appropriations Act, SAM Action was able to fight the industry to a stalemate and prevent protection of the recreational industry.
We did see a victory in that all other attempted pro-marijuana amendments were left out, leaving us with the status quo. The bill also maintains language blocking Washington D.C. from full commercialization and infiltration by Big Pot.
Comprehensive Study Finds Marijuana Legalization Drives Youth Use, Crime Rates, The Black Market, And Harms Communities Of Color
Smart Approaches to Marijuana (SAM), the leading, nonpartisan U.S. organization offering a science-based approach to marijuana policy, released the most comprehensive study to date
entitled: Lessons from Marijuana Legalization in Four U.S. States and D.C. This study, validated by scientists from around the country, found that since legalization, marijuana use has soared, the black market is thriving, and communities of color are being negatively affected.
“The marijuana industry is actively working to become the next Big Tobacco. The use of THC candies and drinks are catering to young people and getting them into the drug at an early age,” said SAM President Kevin Sabet, PhD. “At a time when our nation is struggling with a crippling opioid epidemic, the last thing we need is young people getting caught up in drug use thanks to a relaxing of drug laws. This study should serve as an eye-opener for our policy makers at both the state and federal level,” continued Sabet.
Marijuana Accountability Coalition Unveils “Brought To You By The Pot Industry!” Top 5 Recipients of Big Marijuana Money SAM Officials Speak at United Nations Office of Drugs and Crime Commission on Narcotics in Austria
(MAC) unveiled the results of the “Brought to You by the Pot Industry” campaign. This campaign sought to expose the top recipients of money from the pot industry in Colorado as it works to become the next Big Tobacco.
While each of these legislators may claim to stand for families, communities, and public health, their financial disclosures say otherwise…
MAC also launched the #shareYOURtruthcampaign to share the stories of countless people, families, and communities that have had their lives directly damaged by the use of marijuana. For too long, the only truths being told are those convenient to the booming and unethical marijuana industry.  
SAM Founder and President Dr. Kevin Sabet spent a week at the United Nations Office on Drugs and Crime in Vienna, Austria testifying on the impact of marijuana legalization in the United States
Click the link below to watch the video of his testimony!


Big Marijuana is borrowing the playbook of Big Tobacco in search of the same deep profits at the expense of addicted users. It is time to combat their game with the facts! To help you do so, Smart Approaches to Marijuana (SAM) has partnered with Communities for Alcohol and Drug Free Youth (CADY) to offer a comprehensive media campaign prevention toolkit.

As always, thank you for being a SAM supporter – and please share this recent news far & wide!

Have a great great rest of your week,

Colton Grace

SAM Communications Associate


Posted in Uncategorized | Leave a comment

CANADA: Reefer Madness Strikes Again – Racism, Violence and Hate the Result!

Marijuana-induced psychosis behind Toronto lawyer’s bat attack, judge rules


Mark Phillips arrives at court in St. Thomas, Ont., on April 10, 2018.

As the federal government prepares to legalize the recreational use of marijuana, an Ontario judge has ruled that cannabis-induced psychosis led a man to a seemingly hate-filled attack on a family, in what appears to be the first case of its kind in Canadian criminal courts.

The man who committed the attack, Mark Phillips, is a Toronto lawyer with an otherwise clean record, and the great-grandson of Nathan Phillips, a former mayor after whom the civic square in front of Toronto City Hall is named. The 37-year-old pleaded guilty Tuesday to assault causing harm in the Dec. 7 incident in St. Thomas, in southwestern Ontario, in which he cracked a man’s rib with a baseball bat.

Sergio Estepa was with his wife, Mari, teenage son and a family friend, speaking Spanish in the parking lot of a St. Thomas mall when a stranger, Mr. Phillips, approached and told them to stop speaking French, according to evidence in court.

He then came at them with a baseball bat, repeatedly screaming “ISIS,” saying he was arresting the family, and calling for help. The family also called for help.

Ontario Court Justice John Skowronski said that, in ordinary circumstances, such an attack would call for a penitentiary sentence ­– that is, at least two years in federal prison. But he accepted the recommendation of defence lawyer Steven Skurka that Mr. Phillips be given a conditional discharge, on the condition that he complete three years of probation. A conditional discharge means that, once his probation is successfully finished, Mr. Phillips will not have a criminal record.

Addressing the family, whose members had told the court in emotional victim-impact statements about the nightmares and anxiety they had experienced, Justice Skowronski said he wanted them to know that what happened to them was an aberration for the country. “Canada is a country of immigrants, different nations, skin colours, accents, names,” he said, adding that his name had not come from this country.

“This is something that took place because of a mental illness.”

Although Crown prosecutor Lisa Defoe had urged a suspended sentence and probation, which would have left Mr. Phillips with a criminal record, she, too, had accepted the defence argument that the attack was caused by cannabis-induced psychosis.

“At first blush this may appear to be a hate crime,” she told Justice Skowronski, “but it’s important for the Crown not to react emotionally.”

Mr. Skurka had told the court that Peter Collins, a forensic psychiatrist at the Centre for Addiction and Mental Health in Toronto, had uncovered after several sessions with Mr. Phillips that he had been smoking marijuana heavily, including three or four joints earlier on the day of the attack.

With marijuana legalization on the horizon, the case raises questions about mental-health risks and new challenges for the legal system. According to Mr. Skurka, Dr. Collins warned that higher levels than in the past of tetrahydrocannabinol (THC), the active ingredient in cannabis, is creating a higher incidence of drug-induced psychosis.

For complete story


Posted in Uncategorized | Leave a comment

USA: Facebook Steps Up in Opioid Crisis?

Facebook shuts down drug hashtags on Instagram

Apr 8, 2018

Facebook, the parent company of Instagram, has cracked down on hashtags with drug names such as #fentanyl, #oxycontin, #opioids and more. A search on Saturday for #oxycontin came up with no results, while a search for #fentanyl or #xanax left a posts but also had the message that recent posts “are currently hidden because the community has reported some content that may not meet Instagram’s community guidelines.”

An Instagram spokesperson told CBS News their “community guidelines make it clear that buying or selling prescription drugs isn’t allowed on Instagramand we have zero tolerance when it comes to content that puts the safety of our community at risk.”

Instagram constantly monitors hashtag behavior.

The move comes just days after Food and Drug Administration commissioner Scott Gottlieb criticized social media companies for not doing enough to prevent their sites from being used to sell opioids.

Gottlieb said Wednesday the agency would be inviting the CEOs of major internet companies to a summit to discuss the tech industry’s role in the opioid crisis. Gottlieb said the agency found offers to purchase opioids on a number of social media sites, including Instagram, Facebook, Twitter and Reddit, according to Engadget.

“I know that internet firms are reluctant to cross a threshold, where they could find themselves taking on a broader policing role,” he said. “But these are insidious threats being propagated on these web platforms.”

Glassbreaks CEO Eileen Carey told Wired that she had confronted two executives from Facebook about the hashtags. On March 30, she tweeted at Rob Leathern, Facebook’s director of product management, about the issue. Leathern responded the next day saying the posts had been removed.

For complete story


Posted in Uncategorized | Leave a comment

USA: Mommy’s Marijuana Milk!!

Mom’s Marijuana Winds Up in Breast Milk

By Serena Gordon HealthDay Reporter

MONDAY, April 9, 2018 (HealthDay News) — Breast-feeding has known benefits for both baby and mom, but if a new mom also smokes marijuana, does the drug turn up in her breast milk?

Yes, says new research. But the exact consequences of the small amount of marijuana that makes it to a baby aren’t yet clear.

“This study is just a start to see if marijuana transferred into breast milk. Levels in milk were quite low,” said senior study author Thomas Hale, director of the Infant Risk Center at Texas Tech University School of Medicine in Amarillo.

The researchers also don’t know if the levels of pot in breast milk would rise if a woman smokes more.

Still, study co-author Dr. Teresa Baker, co-director of the Infant Risk Center at Texas Tech, said, “We do not recommend the use of marijuana. There’s concern for the developing brain exposed to THC [the active component in marijuana].”

Both Hale and Baker said that women should abstain from smoking marijuana while breast-feeding because there’s simply no known safe amount.

For complete story


Posted in Uncategorized | Leave a comment